[ Correspondence ]
ABO Blood Type and ARDS

To the Editor:
I read with great interest the article by Reilly et al 1 in a recent issue of CHEST (April 2014). In this article, the authors prospectively studied the association of ABO blood types with ARDS risk in patients with major trauma and severe sepsis. Th e results were very interesting; however, a few pertinent points should be analyzed before these results are accepted into clinical practice.
First, the authors did not hypothesize that sex may modify the association between ABO blood type and ARDS risk. Previous studies found that women were more likely to develop ARDS compared with men, 2 whereas sex is not associated with ABO blood type distribution. Th us, it might be reasonable to hypothesize that the eff ects of ABO blood type on ARDS diff er between men and women. Because the authors had these data, more input could have been gained by carrying out additional analysis to investigate whether sex is an eff ect modifi er.
Second, because the study used a prospective study design, which meant that the interested outcome (ARDS) occurred aft er the exposure, relative risk should have been reported using log-linear regression models rather than the reported OR by logistic regression models. 3 Although an OR can be converted to relative risk, it may have been more informative and intuitive to report relative risk for this prospective study.
Last, the author considered diabetes, alcohol use, and chronic heart failure, among others, as potential confounders in the multivariable models. However, several criteria should be met for a variable to be identifi ed as a potential confounder. One of the criteria is that the potential variable should not be in the pathway between exposure (ABO blood type) and outcome (ARDS). If it is in the pathway, this variable should be considered as a mediator, which cannot be adjusted in the models when total eff ect (direct and indirect eff ect) of ABO blood type on ARDS is the main research question. In this study, some variables, such as diabetes and chronic heart failure, 4 may lie in the pathway between ABO blood type and ARDS, so they should not be adjusted in the fi nal analysis. Th e authors can choose to draw a directed acyclic graph 5 to select which variables should be included in the models. I anticipate that the eff ect of ABO blood type on ARDS would be stronger than reported in the article.
Response
To the Editor:
We thank Dr Zhan for his interest in our recent article in CHEST 1 and for providing the opportunity to discuss our fi ndings of an association between ABO blood type A and increased risk of ARDS in the critically ill. 1 First, Dr Zhan's suggestion that sex may modify the association between ABO blood type and ARDS risk is reasonable because previous research has identifi ed sex diff erences in the same soluble glycoproteins that are associated with both ABO blood types and ARDS. 2 However, we did not detect eff ect modifi cation by sex in either of our populations. Second, we agree that accurate estimations of adjusted relative risks (ARRs) can be obtained given the prospective cohort design of our study. Using postestimation marginal analysis, the adjusted logistic regression [ 1 4 7 # 2 C H E S T F E B R U A R Y 2 0 1 5 ] models can be used to estimate ARRs with accurate CIs. 3 Based on this approach, the ARRs for the association of blood type A and ARDS among subjects of European descent are 1.52 (95% CI, 1.09-2.13; P 5 .013) in the trauma cohort and 1.40 (95% CI, 1.05-1.85; P 5 .021) in the sepsis cohort. Log-linear regression models, another method of estimating ARRs assuming a Poisson distribution, 4 result in nearly identical ARR estimates, 1.52 (95% CI, 1.09-2.12; P 5 .014) in the trauma cohort and 1.39 (95% CI, 1.04-1.86; P 5 .027) in the sepsis cohort.
Dr Zhan also raises the concern that diabetes, alcohol use, and chronic heart failure may lie within the causal pathway of the ABO and ARDS relationship and, therefore, should not be included in adjusted analyses. Of these three covariates, we included only diabetes in the fi nal multivariable models, because ABO blood types have been associated with risk of diabetes in prior studies. 5 Removing diabetes from the logistic regression model does not signifi cantly alter any eff ect estimates of the association of blood type A and ARDS (ARR 1.53 in trauma, 1.39 in sepsis), suggesting that diabetes is neither a confounder nor a causal mediator. Th is was also true when all three variables were either included or excluded from multivariable models. Th erefore, although ABO blood types have been associated with risk of vascular disease and diabetes, 5 , 6 we do not believe the increased risk of ARDS is mediated through these diseases. ARDS develops in the setting of signifi cant environmental insult (eg, trauma or sepsis), resulting in dramatic activation of endothelium and the infl ammatory system. Endothelial-derived glycoproteins linked to ABO blood type, including von Willebrand factor, ICAM-1, and the selectins, are released and/or upregulated by critical illness and may provide the mechanistic link between ABO blood type and ARDS.
